Hansoh Pharmaceutical Group Company Limited (HKG:3692) Investors Are Less Pessimistic Than Expected
Dec 27
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Healthcare Sector Analysis
UpdatedDec 30, 2024
DataAggregated Company Financials
Companies199
- 7D0.6%
- 3M-10.9%
- 1Y-18.6%
- YTD-14.8%
Last week, the Healthcare industry hasn't moved much but Jiangxi Rimag Group is up 10% in that time. As for the longer term, the industry has declined 19% in the last year. As for the next few years, earnings are expected to grow by 29% per annum.
Sector Valuation and Performance
Has the Hong Kong Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 31 Dec 2024 | HK$1.4t | HK$1.4t | HK$28.9b | 11.9x | 47.1x | 1x |
| Thu, 28 Nov 2024 | HK$1.4t | HK$1.4t | HK$28.8b | 11.5x | 47.3x | 1x |
| Sat, 26 Oct 2024 | HK$1.4t | HK$1.4t | HK$30.3b | 12.5x | 47.3x | 1x |
| Mon, 23 Sep 2024 | HK$1.3t | HK$1.5t | HK$31.0b | 11x | 41.6x | 0.9x |
| Wed, 21 Aug 2024 | HK$1.2t | HK$1.4t | HK$28.4b | 10.6x | 43.3x | 0.9x |
| Fri, 19 Jul 2024 | HK$1.2t | HK$1.4t | HK$27.5b | 10.7x | 45.2x | 0.9x |
| Sun, 16 Jun 2024 | HK$1.3t | HK$1.4t | HK$28.7b | 11.2x | 45.7x | 0.9x |
| Tue, 14 May 2024 | HK$1.4t | HK$1.4t | HK$28.8b | 12.5x | 49.1x | 1x |
| Thu, 11 Apr 2024 | HK$1.3t | HK$1.4t | HK$28.6b | 11.3x | 45.4x | 0.9x |
| Sat, 09 Mar 2024 | HK$1.3t | HK$1.4t | HK$26.6b | 11.4x | 49.5x | 0.9x |
| Mon, 05 Feb 2024 | HK$1.2t | HK$1.4t | HK$25.9b | 11.2x | 46.4x | 0.8x |
| Wed, 03 Jan 2024 | HK$1.5t | HK$1.4t | HK$26.5b | 13x | 58.6x | 1.1x |
| Fri, 01 Dec 2023 | HK$1.7t | HK$1.4t | HK$26.1b | 12.9x | 65.3x | 1.2x |
| Sun, 29 Oct 2023 | HK$1.6t | HK$1.4t | HK$24.6b | 12.3x | 65.1x | 1.1x |
| Tue, 26 Sep 2023 | HK$1.6t | HK$1.4t | HK$25.2b | 12.4x | 62.9x | 1.1x |
| Thu, 24 Aug 2023 | HK$1.5t | HK$1.3t | HK$16.9b | 12.7x | 90.6x | 1.1x |
| Sat, 22 Jul 2023 | HK$1.7t | HK$1.4t | HK$2.5b | 13.9x | 664.1x | 1.2x |
| Mon, 19 Jun 2023 | HK$1.8t | HK$1.3t | HK$3.1b | 14.8x | 579.5x | 1.3x |
| Wed, 17 May 2023 | HK$1.9t | HK$1.4t | HK$3.4b | 15.2x | 548.7x | 1.4x |
| Fri, 14 Apr 2023 | HK$2.0t | HK$1.4t | HK$4.5b | 14.1x | 443.3x | 1.5x |
| Sun, 12 Mar 2023 | HK$1.9t | HK$1.3t | -HK$225,162,025.00 | 14.6x | -8272.5x | 1.4x |
| Tue, 07 Feb 2023 | HK$2.0t | HK$1.4t | HK$2.3b | 15.5x | 904.7x | 1.5x |
| Thu, 05 Jan 2023 | HK$2.0t | HK$1.3t | HK$2.0b | 15x | 999.8x | 1.5x |
| Sat, 03 Dec 2022 | HK$1.8t | HK$1.3t | HK$1.9b | 12.6x | 912.6x | 1.3x |
| Mon, 31 Oct 2022 | HK$1.5t | HK$1.3t | HK$1.4b | 12.1x | 1079.4x | 1.2x |
| Wed, 28 Sep 2022 | HK$1.5t | HK$1.3t | HK$2.8b | 12.6x | 541.3x | 1.2x |
| Fri, 26 Aug 2022 | HK$1.7t | HK$1.3t | HK$3.9b | 13.5x | 437.3x | 1.3x |
| Sun, 24 Jul 2022 | HK$1.9t | HK$1.3t | -HK$1,011,978,611.00 | 14.5x | -1882.2x | 1.5x |
| Tue, 21 Jun 2022 | HK$1.8t | HK$1.3t | -HK$3,054,371,460.00 | 14x | -575.9x | 1.3x |
| Thu, 19 May 2022 | HK$1.6t | HK$1.3t | -HK$2,925,203,530.00 | 13.5x | -552.5x | 1.2x |
| Sat, 16 Apr 2022 | HK$1.7t | HK$1.4t | -HK$2,275,234,994.00 | 13.6x | -757.8x | 1.3x |
| Mon, 14 Mar 2022 | HK$1.7t | HK$1.3t | HK$10.1b | 12.8x | 171.5x | 1.3x |
| Wed, 09 Feb 2022 | HK$2.0t | HK$1.3t | HK$7.9b | 14.4x | 246.7x | 1.5x |
| Fri, 07 Jan 2022 | HK$2.2t | HK$1.3t | HK$7.8b | n/a | 279.6x | 1.6x |
Price to Earnings Ratio
279.6x
Current Industry PE
- Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 47.1x which is lower than its 3-year average PE of 120x.
- The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.96x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 55% per year over the last three years.
- Revenues for these companies have grown 2.0% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare sector?
| HK Market | 2.11% | |
| Healthcare | 0.62% | |
| Medical Equipment | 1.64% | |
| Healthcare Services | 1.59% | |
| Life Sciences | 1.19% | |
| Pharma | 0.93% | |
| Healthtech | -0.37% | |
| Biotech | -0.86% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 41.5%, which is higher than its past year's earnings decline of 4.3% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 44% over the next 5 years.
- This is better than its past earnings decline of 37% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 11% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2522 Jiangxi Rimag Group | HK$70.70 | 12.2% +HK$2.7b | n/a | PE4494.3x | |
| 1801 Innovent Biologics | HK$36.10 | 3.0% +HK$1.7b | -15.6% | PS7.5x | |
| 2228 XtalPi Holdings | HK$5.88 | 8.5% +HK$1.6b | n/a | PS95.6x | |
| 2269 WuXi Biologics (Cayman) | HK$17.72 | 2.0% +HK$1.4b | -40.1% | PE26x | |
| 3933 United Laboratories International Holdings | HK$12.30 | 4.8% +HK$1.0b | 75.5% | PE7.2x |
